3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
18
Carcinoma, Non-Small-Cell Lung
11
Squamous Cell Carcinoma of Head and Neck
7
Neoplasms
7
Carcinoma, Renal Cell
7
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Breast Neoplasms
5
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Transitional Cell
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Salivary Gland Neoplasms
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma, Kaposi
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lung Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Colonic Neoplasms
2
Chondrosarcoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Interventions
pembrolizumab
2
Imatinib Mesylate
2
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Protons
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunotherapy
1
GSK-3326595
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Docetaxel
×
Dermatologic
×
Clear all
NCT04140526
2025-05-23
PRESERVE-001
OncoC4, Inc.
Phase 1/2
Active not recruiting
733 enrolled